Key facts
- Notable investors include National Science Foundation Innovation Corps Program, Santa Cruz Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Open Culture Science
- ·The full record, as it builds
Funding rounds
No funding rounds for Open Culture Science are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Open Culture Science
Developer of an automated microfluidic platform designed to enable real-time analysis and monitoring in drug discovery processes. The company's platform focuses on growing, tracking, and analyzing human brain tissue and organ-specific human tissues derived from stem cells, enabling researchers to run more reproducible experiments, increase throughput, and collect continuous functional data without manual intervention.
- Sector
- Healthcare
- HQ
- Santa Cruz, CA, United States
- Founded
- 2024
- Employees
- 3
- Website
- openculturesci.com/
- Ownership
- Privately Held (backing)
Open Culture Science doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Open Culture Science shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Open Culture Science in its N-PORT filings yet. We sweep new filings monthly.